...
机译:CPI-613与高剂量的患有急性髓鞘白血病的高剂量红细胞和尿催化剂组合研究CPI-613的阶段
Wake Forest Baptist Hlth Ctr Comprehens Canc Sect Hematol &
Oncol Winston Salem NC USA;
Wake Forest Baptist Hlth Ctr Comprehens Canc Sect Hematol &
Oncol Winston Salem NC USA;
Wake Forest Baptist Hlth Ctr Comprehens Canc Sect Hematol &
Oncol Winston Salem NC USA;
Wake Forest Publ Hlth Sci Dept Biostat Sci Winston Salem NC USA;
Wake Forest Baptist Hlth Ctr Comprehens Canc Dept Canc Biol Winston Salem NC USA;
Wake Forest Baptist Hlth Ctr Comprehens Canc Dept Canc Biol Winston Salem NC USA;
Wake Forest Publ Hlth Sci Dept Biostat Sci Winston Salem NC USA;
Wake Forest Baptist Hlth Ctr Comprehens Canc Biostat Core Winston Salem NC USA;
Wake Forest Baptist Hlth Ctr Comprehens Canc Dept Canc Biol Winston Salem NC USA;
Wake Forest Baptist Hlth Ctr Comprehens Canc Sect Hematol &
Oncol Winston Salem NC USA;
Wake Forest Baptist Hlth Ctr Comprehens Canc Sect Hematol &
Oncol Winston Salem NC USA;
Wake Forest Baptist Hlth Ctr Comprehens Canc Sect Hematol &
Oncol Winston Salem NC USA;
Wake Forest Baptist Hlth Ctr Comprehens Canc Sect Hematol &
Oncol Winston Salem NC USA;
Wake Forest Baptist Hlth Ctr Comprehens Canc Sect Hematol &
Oncol Winston Salem NC USA;
Wake Forest Baptist Hlth Ctr Comprehens Canc Sect Hematol &
Oncol Winston Salem NC USA;
Wake Forest Baptist Hlth Ctr Comprehens Canc Sect Hematol &
Oncol Winston Salem NC USA;
Wake Forest Baptist Hlth Ctr Comprehens Canc Sect Hematol &
Oncol Winston Salem NC USA;
机译:CPI-613与高剂量的患有急性髓鞘白血病的高剂量红细胞和尿催化剂组合研究CPI-613的阶段
机译:Flagm的II期研究(Fludarabine加上高剂量的溶血性刺激因子加mitoxantrone)用于复发或难治性急性髓性白血病
机译:儿童复发或难治性急性髓细胞性白血病的儿童米托蒽醌和阿糖胞苷的诱导,大剂量阿糖胞苷和依托泊苷的强化治疗:儿童癌症小组研究2951。
机译:计算源自骨髓移植后急性髓性白血病患者复发风险的细胞学图像标志物
机译:Ixazomib的第1/2期作为替代品髓鞘或胭脂瘤患者的替代品的替代物,最近对含有Bortezomib或Carfilzomib的最后组合方案复发或难治
机译:CPI-613联合大剂量阿糖胞苷和米托蒽醌治疗复发或难治性急性髓细胞白血病的I期研究
机译:CPI-613与高剂量的患有急性髓鞘白血病的高剂量红细胞和尿催化剂组合研究CPI-613的阶段